Insurer Transparency Dashboard
Insurers' own published prior-authorization metrics — denial rates, appeal-overturn rates, and decision turnaround times — shown alongside the source for every figure. This is operational transparency, not an attribution of harm to any company.
Compare plans side by side
Each reporting plan's published prior-authorization numbers, color-coded by company. Click a numeric column heading to sort. Every row links to its own source; figures still marked pending primary-source confirmation are third-party aggregations not yet checked against the payer's own CMS-0057-F filing.
| Plan | Denial rate | Appeal overturn | Median turnaround | Type | Source |
|---|---|---|---|---|---|
| Loading plan-level data… | |||||
Loading provenance note…
- Loading data limitations…
The rule behind the numbers
These metrics exist because of a federal transparency rule. Here is what it requires and when.
Loading policy summary…
Transparency, not a body count
Loading explainer…
System-wide picture
Aggregate prior-authorization figures across U.S. insurers, each linked to its published source and badged by provenance.
Loading aggregate metrics…
From a turnaround time to an estimated risk
A plan's published median decision time is a delay length you can put a number on. When a plan reports, for example, that standard prior-authorization decisions take a given number of days, that interval can be entered directly into the Calculator. The calculator applies a peer-reviewed hazard ratio — relative risk modeled as HR(days/28)1 — to estimate the excess mortality RISK associated with a delay of that length, shown with a 95% confidence interval and full methodology. This is a population-level estimate based on the plan's own published timing, clearly labeled as an estimate. It is never a claim that any plan caused any specific death.
Take a turnaround time to the Calculator Read the methodology →
Source: Hanna TP, et al. Mortality due to cancer treatment delay. BMJ 2020;371:m4087. doi:10.1136/bmj.m4087.